title: [Amylasemia in uremics: a complex interpretation].
abstract: Plasmatic amylase increases quite often in uremia. Hyperparathyroidism is also present in uremic patients and it is thought to be the main factor of an increased of amylase; its effect is mediated by an increase of cytosolic calcium. The authors measured the plasmatic level of amylase, lipase, calcium phosphates and parathormone before and after administration of Ca-antagonists (Verapamil and Diltiazem). The results did not shown any correlation. Hyperparathyroidism increased the pancreatic secretion but don't influences the amount of enzymes.
authors.affiliation: Dipartimento di Medicina Interna, Università di Messina.
authors.forename: M
authors.initials: M
authors.lastname: Buemi
authors.forename: M
authors.initials: M
authors.lastname: Molinaro
authors.forename: R
authors.initials: R
authors.lastname: Timpanelli
authors.forename: C
authors.initials: C
authors.lastname: Villari
authors.forename: C
authors.initials: C
authors.lastname: Conti
authors.forename: C
authors.initials: C
authors.lastname: Aloisi
authors.forename: N
authors.initials: N
authors.lastname: Morabito
authors.forename: P
authors.initials: P
authors.lastname: Venuto
authors.forename: N
authors.initials: N
authors.lastname: Frisina
mesh_terms: D000328:Adult; D000368:Aged; D000681:Amylases / Q000097:blood*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000097:blood / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D014511:Uremia / Q000150:complications / Q000188:drug therapy / Q000201:enzymology*
chemical_list: D002121:Calcium Channel Blockers; D000681:Amylases